Tower Research Capital (TRC)’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.01K | Sell |
2,963
-363
| -11% | -$613 | ﹤0.01% | 4237 |
|
|
2025
Q1 | $6.79K | Buy |
3,326
+1,848
| +125% | +$3.77K | ﹤0.01% | 4013 |
|
|
2024
Q4 | $4.86K | Buy |
1,478
+163
| +12% | +$536 | ﹤0.01% | 4385 |
|
|
2024
Q3 | $3.62K | Sell |
1,315
-1,415
| -52% | -$3.89K | ﹤0.01% | 4811 |
|
|
2024
Q2 | $11.1K | Buy |
2,730
+1,604
| +142% | +$6.53K | ﹤0.01% | 4103 |
|
|
2024
Q1 | $7.53K | Buy |
1,126
+578
| +105% | +$3.87K | ﹤0.01% | 4184 |
|
|
2023
Q4 | $2.58K | Sell |
548
-1,199
| -69% | -$5.64K | ﹤0.01% | 5193 |
|
|
2023
Q3 | $7.28K | Sell |
1,747
-1,578
| -47% | -$6.58K | ﹤0.01% | 4484 |
|
|
2023
Q2 | $10.5K | Buy |
3,325
+1,848
| +125% | +$5.82K | ﹤0.01% | 4092 |
|
|
2023
Q1 | $7K | Sell |
1,477
-902
| -38% | -$4.28K | ﹤0.01% | 4713 |
|
|
2022
Q4 | $15K | Buy |
2,379
+1,263
| +113% | +$7.96K | ﹤0.01% | 3398 |
|
|
2022
Q3 | $15K | Sell |
1,116
-1,252
| -53% | -$16.8K | ﹤0.01% | 4151 |
|
|
2022
Q2 | $36K | Buy |
2,368
+696
| +42% | +$10.6K | ﹤0.01% | 3173 |
|
|
2022
Q1 | $62K | Buy |
1,672
+571
| +52% | +$21.2K | ﹤0.01% | 2556 |
|
|
2021
Q4 | $64K | Buy |
1,101
+921
| +512% | +$53.5K | ﹤0.01% | 2563 |
|
|
2021
Q3 | $18K | Sell |
180
-144
| -44% | -$14.4K | ﹤0.01% | 3800 |
|
|
2021
Q2 | $31K | Sell |
324
-179
| -36% | -$17.1K | ﹤0.01% | 3443 |
|
|
2021
Q1 | $51K | Buy |
503
+320
| +175% | +$32.4K | ﹤0.01% | 3102 |
|
|
2020
Q4 | $18K | Sell |
183
-250
| -58% | -$24.6K | ﹤0.01% | 3924 |
|
|
2020
Q3 | $208K | Buy |
433
+360
| +493% | +$173K | ﹤0.01% | 2540 |
|
|
2020
Q2 | $56K | Buy |
+73
| New | +$56K | ﹤0.01% | 2958 |
|